These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17924260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, Huang CF, Wu CC.
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [Abstract] [Full Text] [Related]

  • 3. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF, Cheng CP, Huang CF, Yen JY, Ko CH, Chen CS.
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF, Correll CU.
    J Clin Psychiatry; 2008 Jul; 69 Suppl 1():4-17. PubMed ID: 18484804
    [Abstract] [Full Text] [Related]

  • 6. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders.
    Jónsdóttir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA.
    Acta Psychiatr Scand; 2009 Jan; 119(1):78-84. PubMed ID: 18983630
    [Abstract] [Full Text] [Related]

  • 7. [Adherence to neuroleptic treatment of schizophrenic patients].
    Blondiaux I, Alagille M, Ginestet D.
    Encephale; 1988 Jan; 14(6):431-8. PubMed ID: 2906607
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
    Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP.
    Curr Med Res Opin; 2008 Aug; 24(8):2271-82. PubMed ID: 18588748
    [Abstract] [Full Text] [Related]

  • 10. Coping style of schizophrenic patients in recovery from acute psychotic state.
    Yagi G, Kinoshita F, Nakamura A, Koshiishi M, Kanba S.
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):75-8. PubMed ID: 1679275
    [No Abstract] [Full Text] [Related]

  • 11. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder.
    Sajatovic M, Blow FC, Kales HC, Valenstein M, Ganoczy D, Ignacio RV.
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):992-8. PubMed ID: 17323327
    [Abstract] [Full Text] [Related]

  • 12. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
    Svestka J, Bitter I.
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
    [Abstract] [Full Text] [Related]

  • 13. [Use of Hunperdal Richter in psychiatry].
    Magyar GI, Fadgyas I.
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319
    [Abstract] [Full Text] [Related]

  • 14. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O, Tranulis C.
    Harv Rev Psychiatry; 2009 Jun; 17(1):35-40. PubMed ID: 19205965
    [Abstract] [Full Text] [Related]

  • 15. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
    Tsang HW, Fung KM, Corrigan PW.
    J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
    [Abstract] [Full Text] [Related]

  • 16. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW, Yoon JS, Choi SK.
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A, Goudemand M, Thomas P.
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [Abstract] [Full Text] [Related]

  • 18. [The problem of drug compliance in schizophrenic patients].
    Albus M.
    Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
    [No Abstract] [Full Text] [Related]

  • 19. Haloperidol decanoate.
    Nasser J, Thomas B.
    Aust N Z J Psychiatry; 1989 Sep; 23(3):311-2. PubMed ID: 2803140
    [No Abstract] [Full Text] [Related]

  • 20. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP, Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness.
    J Clin Psychiatry; 2009 Sep; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.